Gino Santini

Gino Santini is Chairman at Lakefront Biotherapeutics since 2026.
Chairman at Collegium Pharmaceutical, Inc. since 2012.
Non Executive Chairman at Compass Pathways Plc since 2024.
Director at ImClone LLC since 2008.
Director at Artax Biopharma, Inc. since 2015.
Independent Director at Enalare Therapeutics, Inc. Former Chairman at National Pharmaceutical Council.
Chairman at AMAG Pharmaceuticals, Inc. from 2014 to 2020.
Chairman at Noble of Indiana.
Lead Independent Director at Intercept Pharmaceuticals, Inc. from 2018 to 2023.
Independent Director at Inspiration Biopharmaceuticals, Inc. Independent Director at Horizon Therapeutics Ltd. (Ireland) from 2012 to 2023.
Independent Director at Sorin SpA from 2012 to 2015.
Independent Director at Vitae Pharmaceuticals LLC from 2015 to 2016.
Director at Greater Indianapolis Chamber of Commerce, Inc. Director at United Way of Central Indiana, Inc. Director at Indiana Chamber of Commerce.
Director at Finanziaria Saccarifera Italo Iberica SpA from 2013 to 2014.
Independent Director at Horizon Pharma, Inc. from 2012 to 2014.
Director at Allena Pharmaceuticals, Inc. from 2012 to 2022.
Director at United Way of The Lewis & Clark.
Director at Intarcia Therapeutics, Inc. SVP-Corporate Strategy & Business Development at Eli Lilly & Co. from 2008 to 2010.
General Manager at Eli Lilly y Cia.
de México SA de CV.
Advisor at Prime Movers Lab LLC.
Education includes an MBA from the University of Rochester Simon Business School in 1983 and an undergraduate degree from Alma Mater Studiorum - Università di Bologna in 1981.